Read the Latest News

Patients Front and Center at the 2018 TMJ Patient-Led RoundTable

It is still all too fresh in the minds of many patients. Fifty years ago, between the 1970s and 1980s, some 10,000 TMJ patients received Vitek jaw implant devices.

Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program

The NIH Common Fund's Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain.

Opportunity to Voice Your Opinion: U.S. Government Officials Want To Hear from Patients with Pain

FDA Public Meeting on Patient-Focused Drug Development for Chronic Pain On July 9, 2018, FDA hosted a public meeting on Patient-Focused Drug Development for Chronic Pain. https://www.federalregister.gov/documents/2018/05/15/2018-10284/patient-focused-

Consider Including the TMJA in Your Financial Planning

We were recently contacted by Tom P. who informed us that he was including The TMJ Association (TMJA), in his financial planning. Tom wrote the following for us to share with our readers:

The Scoop on TMD Pharmaceuticals

Let's say the National Institutes of Health just handed us a multi-million dollar grant to get to the bottom of TMD and find a cure once and for all. I mean, we could start handing out heating pads left and right, but that kind of relief can only get us so far. Whenever I try a different form of therapy or medication, I like to think about the biology, right down to the cellular and molecular level. Why are the cells that make up my jaw region being such jerks?

ACTIVITIES AND PROGRAMS

  • Jun 18, 2014

The TMJ Association (TMJA) continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMD). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs.

  • We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.
  • Our periodicals inform readers of relevant legislative, scientific, and research news. The TMJ Communiqué, a general newsletter, and our TMJ Science journal, a research publication, provide concise, accurate, and newsworthy reports. Our educational materials provide a basic understanding of TMD and related treatment options.
  • We connect TMJ patients in need with other patients who have offered to provide one-on-one support. Our support contacts validate patients' often-doubted pain and disability, reduce isolation, promote self-esteem, and encourage self-reliance and coping skills.
  • The TMJA is shaping a society in which the state of TMD and the pain and suffering they cause are recognized, and effectively managed with scientifically validated treatments.

Back to TMJ Assocation Ltd.

The TMJ Association continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMJDs). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs:

  • We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.
  • Our periodicals inform readers of relevant legislative, scientific, and research news. The TMJ Communiqué, a general newsletter, and our TMJ Science journal, a research publication, provide concise, accurate, and newsworthy reports. Our educational materials provide a basic understanding of TMJDs and related treatment options.
  • We connect TMJ patients in need with other patients who have offered to provide one-on-one support. Our support contacts validate patients' often-doubted pain and disability, reduce isolation, promote self-esteem, and encourage self-reliance and coping skills.
  • The TMJA is shaping a society in which the state of TMJDs and the pain and suffering they cause are recognized, and effectively managed with scientifically validated treatments.

Back to TMJ Assocation Ltd.